MKC1106-MT

BIOLOGICAL2 trials

Sponsors

Mannkind Corporation

Conditions

Melanoma (Skin)Stage III MelanomaStage IV Melanoma

Phase 1

Vaccine Therapy in Treating Patients With Stage IV Melanoma

CompletedNCT00033228

Mannkind CorporationMelanoma (Skin)

Start: 2002-01-31End: 2003-04-30Updated: 2011-05-12

Phase 2

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

TerminatedNCT01026051

Mannkind CorporationStage III Melanoma, Stage IV Melanoma

Start: 2010-10-31End: 2012-07-31Updated: 2012-05-15